Notably, three-step DOTA-PRIT based on [177Lu]Lu-ABD has shown excellent therapeutic efficacy without treatment-related toxicities in subcutaneous GPA33-expressing human CRC xenograft mice 12-14, 19. Here, GPA33 is linked to colorectal carcinoma.